Page last updated: 2024-08-24

azelnidipine and Amyloid Angiopathy, Cerebral

azelnidipine has been researched along with Amyloid Angiopathy, Cerebral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Askarova, S; Lee, JC; Ridgley, DM; Sun, GY; Teng, T; Tsoy, A	1

Other Studies

1 other study(ies) available for azelnidipine and Amyloid Angiopathy, Cerebral

Article	Year
Azelnidipine Attenuates the Oxidative and NFκB Pathways in Amyloid-β-Stimulated Cerebral Endothelial Cells. ACS chemical neuroscience, 2019, 01-16, Volume: 10, Issue:1 Topics: Amyloid beta-Peptides; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cell Line, Transformed; Cerebral Amyloid Angiopathy; Cerebral Cortex; Dihydropyridines; Endothelial Cells; Mice; NF-kappa B; Oxidative Stress; Signal Transduction	2019

Article

Year

Azelnidipine Attenuates the Oxidative and NFκB Pathways in Amyloid-β-Stimulated Cerebral Endothelial Cells.

ACS chemical neuroscience, 2019, 01-16, Volume: 10, Issue:1

Topics: Amyloid beta-Peptides; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cell Line, Transformed; Cerebral Amyloid Angiopathy; Cerebral Cortex; Dihydropyridines; Endothelial Cells; Mice; NF-kappa B; Oxidative Stress; Signal Transduction

2019